_version_ 1827331215101788160
author Anne Largeot
Vanessa Klapp
Elodie Viry
Susanne Gonder
Iria Fernandez Botana
Arnaud Blomme
Mohaned Benzarti
Sandrine Pierson
Chloé Duculty
Petra Marttila
Marina Wierz
Ernesto Gargiulo
Giulia Pagano
Ning An
Najla El Hachem
Daniel Perez Hernandez
Supriya Chakraborty
Loic Ysebaert
Jean-Hugues François
Susan Cortez
Guy Berchem
Dimitar G Efremov
Gunnar Dittmar
Martyna Szpakowska
Andy Chevigne
Petr V. Nazarov
Thomas Helleday
Pierre Close
Johannes Meiser
Basile Stamatopoulos
Laurent Désaubry
Jérôme Paggetti
Etienne Moussay
author_facet Anne Largeot
Vanessa Klapp
Elodie Viry
Susanne Gonder
Iria Fernandez Botana
Arnaud Blomme
Mohaned Benzarti
Sandrine Pierson
Chloé Duculty
Petra Marttila
Marina Wierz
Ernesto Gargiulo
Giulia Pagano
Ning An
Najla El Hachem
Daniel Perez Hernandez
Supriya Chakraborty
Loic Ysebaert
Jean-Hugues François
Susan Cortez
Guy Berchem
Dimitar G Efremov
Gunnar Dittmar
Martyna Szpakowska
Andy Chevigne
Petr V. Nazarov
Thomas Helleday
Pierre Close
Johannes Meiser
Basile Stamatopoulos
Laurent Désaubry
Jérôme Paggetti
Etienne Moussay
author_sort Anne Largeot
collection DOAJ
first_indexed 2024-03-07T16:32:55Z
format Article
id doaj.art-cadb7e0ab439425bb2d02339f658e7b0
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:32:55Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-cadb7e0ab439425bb2d02339f658e7b02024-03-03T10:10:15ZengWileyHemaSphere2572-92412023-08-017e52627ab10.1097/01.HS9.0000967476.52627.ab202308003-00043S141: INHIBITION OF MYC TRANSLATION THROUGH TARGETING OF THE NEWLY IDENTIFIED PHB-EIF4F COMPLEX AS THERAPEUTIC STRATEGY INCHRONIC LYMPHOCYTIC LEUKEMIA (CLL)Anne Largeot0Vanessa Klapp1Elodie Viry2Susanne Gonder3Iria Fernandez Botana4Arnaud Blomme5Mohaned Benzarti6Sandrine Pierson7Chloé Duculty8Petra Marttila9Marina Wierz10Ernesto Gargiulo11Giulia Pagano12Ning An13Najla El Hachem14Daniel Perez Hernandez15Supriya Chakraborty16Loic Ysebaert17Jean-Hugues François18Susan Cortez19Guy Berchem20Dimitar G Efremov21Gunnar Dittmar22Martyna Szpakowska23Andy Chevigne24Petr V. Nazarov25Thomas Helleday26Pierre Close27Johannes Meiser28Basile Stamatopoulos29Laurent Désaubry30Jérôme Paggetti31Etienne Moussay321 Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg1 Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg1 Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg1 Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg1 Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg2 GIGA Cancer, Liège, Belgium1 Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg1 Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg1 Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg3 Karolinska Institutet, Solna, Sweden1 Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg1 Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg1 Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg2 GIGA Cancer, Liège, Belgium2 GIGA Cancer, Liège, Belgium4 Luxembourg Institue of Health, DII, Luxembourg, Luxembourg5 International Centre for Genetic Engineering and Biotechnology, Trieste, Italy6 Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France7 Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg7 Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg7 Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg5 International Centre for Genetic Engineering and Biotechnology, Trieste, Italy4 Luxembourg Institue of Health, DII, Luxembourg, Luxembourg4 Luxembourg Institue of Health, DII, Luxembourg, Luxembourg4 Luxembourg Institue of Health, DII, Luxembourg, Luxembourg1 Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg3 Karolinska Institutet, Solna, Sweden2 GIGA Cancer, Liège, Belgium1 Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg8 ULB-Research Cancer Center (U-CRC), Jules Bordet Institute, Brussels, Belgium9 INSERM-University of Strasbourg, Strasbourg, France1 Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg1 Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourghttp://journals.lww.com/10.1097/01.HS9.0000967476.52627.ab
spellingShingle Anne Largeot
Vanessa Klapp
Elodie Viry
Susanne Gonder
Iria Fernandez Botana
Arnaud Blomme
Mohaned Benzarti
Sandrine Pierson
Chloé Duculty
Petra Marttila
Marina Wierz
Ernesto Gargiulo
Giulia Pagano
Ning An
Najla El Hachem
Daniel Perez Hernandez
Supriya Chakraborty
Loic Ysebaert
Jean-Hugues François
Susan Cortez
Guy Berchem
Dimitar G Efremov
Gunnar Dittmar
Martyna Szpakowska
Andy Chevigne
Petr V. Nazarov
Thomas Helleday
Pierre Close
Johannes Meiser
Basile Stamatopoulos
Laurent Désaubry
Jérôme Paggetti
Etienne Moussay
S141: INHIBITION OF MYC TRANSLATION THROUGH TARGETING OF THE NEWLY IDENTIFIED PHB-EIF4F COMPLEX AS THERAPEUTIC STRATEGY INCHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
HemaSphere
title S141: INHIBITION OF MYC TRANSLATION THROUGH TARGETING OF THE NEWLY IDENTIFIED PHB-EIF4F COMPLEX AS THERAPEUTIC STRATEGY INCHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
title_full S141: INHIBITION OF MYC TRANSLATION THROUGH TARGETING OF THE NEWLY IDENTIFIED PHB-EIF4F COMPLEX AS THERAPEUTIC STRATEGY INCHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
title_fullStr S141: INHIBITION OF MYC TRANSLATION THROUGH TARGETING OF THE NEWLY IDENTIFIED PHB-EIF4F COMPLEX AS THERAPEUTIC STRATEGY INCHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
title_full_unstemmed S141: INHIBITION OF MYC TRANSLATION THROUGH TARGETING OF THE NEWLY IDENTIFIED PHB-EIF4F COMPLEX AS THERAPEUTIC STRATEGY INCHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
title_short S141: INHIBITION OF MYC TRANSLATION THROUGH TARGETING OF THE NEWLY IDENTIFIED PHB-EIF4F COMPLEX AS THERAPEUTIC STRATEGY INCHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
title_sort s141 inhibition of myc translation through targeting of the newly identified phb eif4f complex as therapeutic strategy inchronic lymphocytic leukemia cll
url http://journals.lww.com/10.1097/01.HS9.0000967476.52627.ab
work_keys_str_mv AT annelargeot s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT vanessaklapp s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT elodieviry s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT susannegonder s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT iriafernandezbotana s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT arnaudblomme s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT mohanedbenzarti s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT sandrinepierson s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT chloeduculty s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT petramarttila s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT marinawierz s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT ernestogargiulo s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT giuliapagano s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT ningan s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT najlaelhachem s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT danielperezhernandez s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT supriyachakraborty s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT loicysebaert s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT jeanhuguesfrancois s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT susancortez s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT guyberchem s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT dimitargefremov s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT gunnardittmar s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT martynaszpakowska s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT andychevigne s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT petrvnazarov s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT thomashelleday s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT pierreclose s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT johannesmeiser s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT basilestamatopoulos s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT laurentdesaubry s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT jeromepaggetti s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll
AT etiennemoussay s141inhibitionofmyctranslationthroughtargetingofthenewlyidentifiedphbeif4fcomplexastherapeuticstrategyinchroniclymphocyticleukemiacll